Belgian healthtech startup IntelliProve has raised €2.7 million in Seed funding. Miles Ahead led the round with participation from Wit-Gele Kruis, imec.istart, and business angels. The company builds camera software that measures health indicators from a 30-second face scan.
Funding so far
This is IntelliProve's third announced round. The company closed a €1 million Seed round in November 2022 and a €1.25 million Seed round in January 2025. Miles Ahead also led the 2025 round.
Company context
IntelliProve was founded in 2021 and works with TU Delft and Ghent University Hospital. Its ISO 27001-certified technology is used by virtual care, health insurance, and wellbeing platforms in more than 50 countries. The company operates from Ghent, Belgium.
How the technology works
The scan measures heart rate, heart rate variability, respiratory rate, systolic and diastolic blood pressure, and resonant breathing. The software uses remote photoplethysmography to spot small skin color changes from each heartbeat. Its VitalMesh, TripleGate, and PulseShape tools handle movement, lighting, and signal quality.
The new capital will support broader datasets across skin tones, ages, lighting, and devices. IntelliProve also plans clinical validation, accuracy benchmarks, and Class IIa certification under the EU Medical Device Regulation. The company aims to expand virtual care partnerships and bring the technology to humanoid robots and other camera devices.